Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C

TLDR

Liver biopsy is the gold standard for fibrosis assessment but has several limitations. This study evaluated diffusion‑weighted MRI, which measures the apparent diffusion coefficient, as a noninvasive diagnostic tool for liver fibrosis in chronic hepatitis C patients. The authors prospectively examined 20 healthy volunteers and 54 HCV patients across METAVIR stages F0–F4. Patients with moderate‑to‑severe fibrosis had lower ADC values, and DWMRI achieved AUCs of 0.92 for F3‑F4 and 0.79 for F2‑F4, with 87 % sensitivity and 87 % specificity at a 1.21 × 10⁻³ mm²/s cutoff, indicating performance comparable to elastography and superior to other noninvasive tests. Published in Hepatology (2007).

Abstract

Liver biopsy is the gold standard for assessing fibrosis but has several limitations. We evaluated a noninvasive method, so-called diffusion-weighted magnetic resonance imaging (DWMRI), which measures the apparent diffusion coefficient (ADC) of water, for the diagnosis of liver fibrosis in patients with chronic hepatitis C virus (HCV). We analyzed 20 healthy volunteers and 54 patients with chronic HCV (METAVIR: F0, n = 1; F1, n = 30; F2, n = 8; F3, n = 5; and F4, n = 10) prospectively included. Patients with moderate-to-severe fibrosis (F2-F3-F4) had hepatic ADC values lower than those without or with mild fibrosis (F0-F1; mean: 1.10 ± 0.11 versus 1.30 ± 0.12 × 10−3 mm2/s) and healthy volunteers (mean: 1.44 ± 0.02 × 10−3 mm2/s). In discriminating patients staged F3-F4, the areas under the receiving operating characteristic curves (AUCs) were 0.92 (±0.04) for magnetic resonance imaging (MRI), 0.92 (±0.05) for elastography, 0.79 (±0.08) for FibroTest, 0.87 (±0.06) for the aspartate aminotransferase to platelets ratio index (APRI), 0.86 (±0.06) for the Forns index, and 0.87 (±0.06) for hyaluronate. In these patients, the sensitivity, specificity, positive predictive value, and negative predictive value were 87%, 87%, 72%, and 94%, respectively, with an ADC cutoff level of 1.21 × 10−3 mm2/s. In discriminating patients staged F2-F3-F4, the AUC values were 0.79 (±0.07) for MRI, 0.87 (±0.05) for elastography, 0.68 (±0.09) for FibroTest, 0.81 (±0.06) for APRI, 0.72 (±0.08) for the Forns index, and 0.77 (±0.06) for hyaluronate. Conclusion: This preliminary study suggests that DWMRI compares favorably with other noninvasive tests for the presence of significant liver fibrosis. (Hepatology 2007.)